Sign in

CIK 0001062822

  • Non-accelerated filer
  • Smaller reporting company

LEXICON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
LXRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760474169
Phone
+1 281-863-3000
Business address
2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
Former names
LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
  1. 4 Shares withheld for taxes SVP, Regulatory & QA gave up 24,353 shares (to pay taxes)
  2. 4 Shares withheld for taxes SVP, Chief Medical Officer gave up 31,265 shares (to pay taxes)
  3. 4 Shares withheld for taxes SVP, General Counsel & Secr. gave up 25,604 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Executive Officer gave up 61,371 shares (to pay taxes)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Chief Executive Officer bought 90,000 shares at $1.05 ($94,797)
  15. 4 Open-market buy Director bought 200,000 shares at $1.01 ($201,520)
  16. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.01 ($10,100)
  17. 4 Open-market buy Director bought 1,000,000 shares at an average $1.10 ($1,103,957)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market buy President and CFO bought 10,000 shares at $1.38 ($13,800)

Page 6 of 34 · 673 filings